NCT04421586

Brief Summary

The purpose of this study is to understand why parents do or do not vaccinate their children and explore what information parents need to vaccinate their children. The study will test whether information about vaccinations provided during pregnancy by a health provider (VISTA intervention) may improve the possibility that a child is vaccinated on time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

September 2, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2021

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

January 5, 2024

Completed
Last Updated

January 5, 2024

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

June 4, 2020

Results QC Date

May 23, 2022

Last Update Submit

March 20, 2023

Conditions

Keywords

vaccine hesitancy

Outcome Measures

Primary Outcomes (1)

  • Percentage of Women With Reduced Number of Concerns Immediately Post-counseling in the Intervention Arm

    Post-counseling (Baseline visit)

Secondary Outcomes (15)

  • Percentage of Women With Reduced Number of Concerns in Intervention Versus Control Arms at Follow up.

    Follow-up (up to 6 months post-birth; up to 9 months post-baseline)

  • Percentage of Children by Vaccine Who Received the Vaccine Within 4-week Window of Due Date in Intervention Versus Control Arm

    Follow-up (up to 6 months post-birth; up to 9 months post-baseline)

  • Median Number of Days Children Remain Unvaccinated for Each Vaccine in Intervention Versus Control Arm

    Follow-up (up to 6 months post-birth; up to 9 months post-baseline)

  • Percentage of Checklist Items Completed During Counseling in VISTA Intervention Arm

    Baseline

  • Mean Number of Minutes Spent Delivering Counseling Per Woman in VISTA Intervention Arm

    Baseline

  • +10 more secondary outcomes

Study Arms (2)

Pregnant women receiving VISTA counseling

EXPERIMENTAL

Up to 30 pregnant women are screened and counseled for vaccine concerns using VISTA

Behavioral: VISTA

Pregnant women receiving usual care

NO INTERVENTION

Up to 30 pregnant women receiving usual care

Interventions

VISTABEHAVIORAL

VISTA will be an educational intervention.

Pregnant women receiving VISTA counseling

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Study outcomes will be measured for health providers implementing the intervention and pregnant women receiving the intervention. Up to 10 health workers (including community health workers (CHW) from each of the intervention sites will participate in the study.
  • To participate in the study,
  • Health workers must be:
  • years of age or older
  • Work in one of the study intervention sites
  • Women must be:
  • In the third trimester of pregnancy
  • Residing in a study site (intervention or control)
  • At least 15 years of age
  • Planning to reside in the study site for the duration of their participation in the study (until approximately 6 months after delivery to enable follow up).
  • Have at least 1 concern about childhood vaccines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute for Medical Research (NIMR)

Mtwara, Tanzania

Location

MeSH Terms

Conditions

Vaccination Hesitancy

Condition Hierarchy (Ancestors)

Vaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Limitations and Caveats

Vaccination data for one child in the usual care group was uninterpretable, hence, excluded from assessment of vaccination timeliness outcomes.

Results Point of Contact

Title
Lavanya Vasudevan, Ph.D.
Organization
Duke University

Study Officials

  • Lavanya Vasudevan, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 9, 2020

Study Start

September 2, 2020

Primary Completion

May 24, 2021

Study Completion

May 24, 2021

Last Updated

January 5, 2024

Results First Posted

January 5, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations